Abstract
Wound healing represents a significant challenge within the field of medical science. Contemporary clinical practices increasingly favor the utilization of herbal compounds to facilitate the repair process. Among these compounds, coumarin-a phytochemical noted for its antibacterial and wound-healing properties-has garnered considerable attention. This study investigates the potential advantages of incorporating coumarin into wound dressings within an experimental model. Our synthesized target compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one (CPPI) demonstrated notable antimicrobial activity against the pathogenic Staphylococcus aureus MRSA, Bacillus cereus, and Pseudomonas aeruginosa. Moreover, both in vitro and in vivo experiments showed that CPPI significantly enhanced the migration of skin fibroblast cells and promoted the wound healing process. Furthermore, it facilitated complete re-epithelialization of the wounds. Histological analysis revealed the formation of well-structured granulation tissue and a reduction in indicators of wound infection, evidenced by a minimal presence of inflammatory cells in comparison to untreated wounds. Additionally, in silico molecular docking studies of CPPI indicated significant binding affinity within COX-2 active site along with a stable complex during molecular dynamics simulations. Collectively, the findings of this study suggest that CPPI can provide a protective effect against infections in cutaneous wounds, attributable to its antimicrobial properties.
Data availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Byrd, A. L., Belkaid, Y. & Segre, J. A. The human skin Microbiome. Nat. Rev. Microbiol. 16, 143 (2018).
Dandona, R. et al. Mortality due to road injuries in the States of india: The global burden of disease study 1990–2017. Lancet Public. Health. 5, e86 (2020).
Graves, N., Phillips, C. J. & Harding, K. A narrative review of the epidemiology and economics of chronic wounds. Br. J. Dermatol. 187, 141 (2022).
Rezvani Ghomi, E., Khalili, S., Nouri Khorasani, S., Esmaeely Neisiany, R. & Ramakrishna, S. Wound dressings: Current advances and future directions. J. Appl. Polym. Sci. 136, 47738 (2019).
Bryson, A. L. & Doern, C. D. Wound cultures. In Clinical microbiology procedures handbook (eds. Leber, A. L. & Burnham, C. A.) 5th ed., Aerobic Bacteriology, Chap. 3.12 (John Wiley & Sons, Hoboken, NJ, (2023).
Ahovan, Z. A. et al. Antibacterial smart hydrogels: New hope for infectious wound management. Mater. Today Bio. 17, 100499 (2022).
Batran, R. Z. et al. Synthesis and mechanistic insights of coumarinyl-Indolinone hybrids as potent inhibitors of leishmania major. Eur. J. Med. Chem. 288, 117392 (2025).
Ebaid, M. S. et al. Identification of coumarin-chalcone and coumarin-pyrazoline derivatives as novel anti-toxoplasma gondii agents. Drug Des. Dev. Ther. 18, 5599 (2024).
Batran, R. Z. et al. Design, synthesis and molecular modeling of pyrazoline based coumarin derivatives as tubulin polymerization inhibitors. J. Mol. Struct. 1318, 139123 (2024).
Sabt, A. et al. New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: Design, synthesis, dual BRAF V600E/VEGFR-2 inhibition, and computational studies. RSC Adv. 14, 5907 (2024).
Batran, R. Z., Ahmed, E. Y., Nossier, E. S., Awad, H. M. & Latif, N. A. Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: Synthesis, molecular modeling, TrkA, PI3K/AKT and EGFR Inhibition. J. Mol. Struct. 1305, 137790 (2024).
Batran, R. Z., Sabt, A., Dziadek, J. & Kassem, A. F. Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti-mycobacterium tuberculosis agents targeting Enoyl acyl carrier protein reductase (InhA). RSC Adv. 14, 21763 (2024).
Batran, R. Z., Ahmed, E. Y., Awad, H. M., Ali, K. A. & Latif, N. A. EGFR and PI3K/m-TOR inhibitors: Design, microwave assisted synthesis and anticancer activity of thiazole–coumarin hybrids. RSC Adv. 13, 29070 (2023).
Sharifi-Rad, J. et al. Natural coumarins: Exploring the pharmacological complexity and underlying molecular mechanisms. Oxid. Med. Cell Longev. 6492346 (2021). (2021).
Giovannuzzi, S. et al. Coumarins effectively inhibit bacterial α-carbonic anhydrases. J. Enzyme Inhib. Med. Chem. 37, 333 (2022).
Batran, R. Z. et al. 4-Phenylcoumarin derivatives as new HIV-1 nnrtis: Design, synthesis, biological activities, and computational studies. Bioorg. Chem. 141, 106918 (2023).
Batran, R. Z., Khedr, M. A., Latif, N. A., El Aty, A. & Shehata, A. A. Synthesis, homology modeling, molecular docking, dynamics, and antifungal screening of new 4-hydroxycoumarin derivatives as potential chitinase inhibitors. J. Mol. Struct. 1180, 260 (2019).
Bettia, N., Shiab, J. S., Kadhumc, A. A. & Al-Amieryd, A. A. Harnessing coumarin chemistry: Antibacterial, antifungal, and antioxidant profiling of novel coumarin derivatives. J. Med. Pharm. Chem. Res. 6, 1530 (2024).
Afshar, M., Hassanzadeh-Taheri, M., Zardast, M. & Honarmand, M. Efficacy of topical application of coumarin on incisional wound healing in BALB/c mice. Iran. J. Dermatol. 23, 56 (2020).
Sahoo, J. & Kumar, P. S. Biological evaluation and spectral characterization of 4-hydroxy coumarin analogues. J. Taibah Univ. Med. Sci. 10, 306 (2015).
Dutra, F. V. et al. Coumarin/β-Cyclodextrin inclusion complexes promote acceleration and improvement of wound healing. ACS Appl. Mater. Interfaces. 16, 30900 (2024).
Kim, T. Y. et al. Iridoid glycosides and coumarin glycoside derivatives from the roots of nymphoides peltata and their In vitro wound healing properties. Int. J. Mol. Sci. 25, 1268 (2024).
De, S. et al. Pyridine: the scaffolds with significant clinical diversity. Rsc Adv. 12, 15385 (2022).
Ali, I. et al. Synthesis and characterization of pyridine-based organic salts: Their antibacterial, antibiofilm and wound healing activities. Bioorg. Chem. 100, 103937 (2020).
Batran, R. Z., Ahmed, E. Y., Awad, H. M. & Latif, N. A. Naturally based pyrazoline derivatives as aminopeptidase N, VEGFR2 and MMP9 inhibitors: Design, synthesis and molecular modeling. RSC Adv. 14, 22434 (2024).
Sohn, E. H., Kim, S. N. & Lee, S. R. Melatonin’s impact on wound healing. Antioxidants 13, 1197 (2024).
Elsayed, M. A., Elsayed, A. M. & Sroor, F. M. Novel biologically active pyridine derivatives: Synthesis, structure characterization, in vitro antimicrobial evaluation and structure-activity relationship. Med. Chem. Res. 33, 476 (2024).
Li, G. et al. Pyrazole-containing pharmaceuticals: Target, pharmacological activity, and their SAR studies. RSC Med. Chem. 13, 1300 (2022).
Seo, G. Y. et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J. Biomed. Sci. 22, 1 (2015).
Shirinzadeh, H., Süzen, S., Altanlar, N. & Westwell, A. D. Antimicrobial activities of new Indole derivatives containing 1, 2, 4-triazole, 1, 3, 4-thiadiazole and carbothioamide. Turk. J. Pharm. Sci. 15, 291 (2018).
Sabarees, G., Velmurugan, V., Gouthaman, S., Solomon, V. R. & Kandhasamy, S. Fabrication of quercetin-functionalized morpholine and pyridine Motifs-Laden silk fibroin nanofibers for effective wound healing in preclinical study. Pharmaceutics 16, 462 (2024).
Elsayed, R. E., Madkour, T. M. & Azzam, R. A. Tailored-design of electrospun nanofiber cellulose acetate/poly (lactic acid) dressing Mats loaded with a newly synthesized sulfonamide analog exhibiting superior wound healing. Int. J. Biol. Macromol. 164, 1984 (2020).
Qin, H. L., Zhang, Z. W., Ravindar, L. & Rakesh, K. P. Antibacterial activities with the structure-activity relationship of coumarin derivatives. Eur. J. Med. Chem. 207, 112832 (2020).
Venugopala, K. N., Rashmi, V. & Odhav, B. Review on natural coumarin lead compounds for their Pharmacological activity. Biomed. Res. Int. 963248 2013 (2013).
Aatif, M. et al. Potential nitrogen-based heterocyclic compounds for treating infectious diseases: A literature review. Antibiotics 11, 1750 (2022).
Sabt, A., Abdelrahman, M. T., Abdelraof, M. & Rashdan, H. R. Investigation of novel mucorales fungal inhibitors: Synthesis, in-silico study and anti-fungal potency of novel class of coumarin-6-sulfonamides-thiazole and thiadiazole hybrids. ChemistrySelect 7, e202200691 (2022).
Abo-Salem, H. M. et al. Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration. Int. J. Biol. Macromol. 272, 132631 (2024).
El-Sawy, E. R., Abdel-Aziz, M. S., Abdelmegeed, H. & Kirsch, G. Coumarins: Quorum sensing and biofilm formation Inhibition. Molecules 29, 4534 (2024).
Sahoo, C. R. et al. Coumarin derivatives as promising antibacterial agent (s). Arab. J. Chem. 14, 102922 (2021).
Cheke, R. S. et al. Molecular insights into coumarin analogues as antimicrobial agents: Recent developments in drug discovery. Antibiotics 11, 566 (2022).
Kim, D. Y., Kang, Y. H. & Kang, M. K. Umbelliferone alleviates impaired wound healing and skin barrier dysfunction in high glucose-exposed dermal fibroblasts and diabetic skins. J. Mol. Med. 102, 1457 (2024).
Adams, D. H., Shou, Q., Wohlmuth, H. & Cowin, A. J. Native Australian plant extracts differentially induce collagen I and collagen III in vitro and could be important targets for the development of new wound healing therapies. Fitoterapia 109, 45 (2016).
Pooranachithra, M. et al. Unravelling the wound healing ability and mode of action of pyridine Carboxamide oxime using caenorhabditis elegans as potential prescreen wound model. Life Sci. 235, 116859 (2019).
Morrison, D. K. MAP kinase pathways. Cold Spring Harb Perspect. Biol. 4, a011254 (2012).
Abdelhafez, O. M. et al. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg. Med. Chem. 18, 3371 (2010).
Nirusha, K. et al. Exploration of piperazine-citral sulfonyl derivatives: Antibacterial and in-silico studies against methicillin-resistant Staphylococcus aureus. Arch. Microbiol. 207, 562025 (2025).
He, M. M. et al. Small-molecule Inhibition of TNF-α. Science 310, 1022 (2005).
Gilbert, N. C. et al. Structural and mechanistic insights into 5-lipoxygenase Inhibition by natural products. Nat. Chem. Biol. 16, 783 (2020).
Harman, C. A. et al. Structural basis of enantioselective Inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. J. Biol. Chem. 282, 28096 (2007).
Orlando, B. J. & Malkowski, M. G. Substrate-selective Inhibition of cyclooxygeanse-2 by Fenamic acid derivatives is dependent on peroxide tone. J. Biol. Chem. 291, 15069 (2016).
Chaikuad, A. et al. A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. Nat. Chem. Biol. 10, 853 (2014).
MarvinSketch (version 22.2, by ChemAxon).
Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated Docking with selective receptor flexibility. J. Comput. Chem. 30, 2785 (2009).
Trott, O. & Olson, A. J. AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455 (2010).
BIOVIA & Systèmes, D. Discovery Studio Visualizer, V25.1.0 (Dassault Systèmes, 2025).
Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405 (2016).
Brooks, B. R. et al. Caflisch, A. CHARMM: The biomolecular simulation program. J. Comput. Chem. 30, 1545 (2009).
Aboukhatwa, S. M. et al. Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase Inhibition. Bioorg. Chem. 129, 106126 (2022).
Abraham, M. J. et al. High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX GROMACS, 1, 19 (2015).
Kumari, R., Kumar, R., Open Source, Drug Discovery Consortium & Lynn, A. g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951 (2014).
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive funding.
Author information
Authors and Affiliations
Contributions
A.S., E.Y.A and R.Z.B contributed to conceptualization and design of the research work. A.S., E.Y.A, M.M.E and R.Z.B participated in the synthesis and purification of the compounds, and analysis of spectra data. H.A., A.H. A., A.A.F.S. and M.A. performed the biological tests. M.B. and M.A.S conducted molecular docking and dynamic simulations studies. M.G.T., A.M.R. and M.A.A. contributed to visualization. N.A.L. and R.Z.B contributed to supervision, A.S., H.A., A.H.A., M.B., M.A.S., A.A.F.S., M.A., E.Y.A. participated in writing and editing the original manuscript draft. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study was conducted according to the appropriate ethical standards as required by guidance from the Research Ethics Committee, Faculty of Pharmacy, Egyptian Russian University, Egypt, Ethical Approval No. ERUFP-PC-24005.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sabt, A., Abdelmegeed, H., Abdel-Razik, AR.H. et al. Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recovery. Sci Rep (2026). https://doi.org/10.1038/s41598-026-37714-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-37714-5
